Loading data…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$54.13M net income for the year ended February 28, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| March 2, 2025 – February 28, 2026 | $1,404,733,000 | April 24, 2026 | 10-K ↗ |
| March 3, 2024 – March 1, 2025 | $1,360,994,000 | April 24, 2026 | 10-K ↗ |
| February 26, 2023 – March 2, 2024 | $1,416,942,000 | April 24, 2026 | 10-K ↗ |
| February 27, 2022 – February 25, 2023 | $1,440,696,000 | April 24, 2025 | 10-K ↗ |
| February 28, 2021 – February 26, 2022 | $1,313,977,000 | April 26, 2024 | 10-K ↗ |
| March 1, 2020 – February 27, 2021 | $1,230,774,000 | April 21, 2023 | 10-K ↗ |
| March 3, 2019 – February 29, 2020 | $1,387,439,000 | April 22, 2022 | 10-K ↗ |
| March 4, 2018 – March 2, 2019 | $1,402,637,000 | April 22, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 13, 2026
Response SHA-256: a3b62fd57067d49481736231248a04df45a290b0165a0bfdfbdf8e05bb1809c7
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.